Levonorgestrel IUD for Emergency Contraception and Same-Day Start
Official title: Levonorgestrel IUD for Emergency Contraception & Same-Day Start Study
Funded at Utah State Higher Education System--University of Utah · NIH-11380012 · Data updated 2026-11-12
A study is testing whether the LNG 52 mg IUD can be used effectively for emergency contraception and started the same day in eligible people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | July 27, 2015 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $564,266 |
| NIH project number | 5R01HD083340-09 |
| Project ID | NIH-11380012 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals seeking emergency contraception or considering same-day LNG IUD placement who meet standard clinical eligibility.
✕Less likely to help
People with contraindications to LNG IUD or who seek non-IUD contraception may not benefit.
What this research studies
This project builds on a prior trial showing the LNG 52 mg IUD works for emergency contraception and may be as effective as copper IUDs. Researchers will look at real-world use and how to expand access, including same-day start in more clinical settings. The study designs and analyzes outcomes to see if broader guidelines could safely support earlier and wider use. This information could help patients avoid unintended pregnancies by offering a reliable, long-acting option at the point of care.
Why it matters
Potential benefit: If successful, this could expand access to a highly effective emergency contraception option and allow same-day IUD placement in more clinics.
How similar studies have gone: Prior RAPID EC trial showed very low pregnancy with LNG IUD for EC, supporting potential impact.
Where this research is happening
-
Utah State Higher Education System--University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Turok, David — Utah State Higher Education System--University of Utah
- Study coordinator: Turok, David
Related research
Other NIH-funded projects on the same topics.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Blocking CFTR in the cervix to prevent conception without hormones
A non-hormonal approach aims to stop sperm from entering the uterus by making cervical mucus too thick for sperm, potentially offering a new contraception option.
-
Long‑lasting antibody vaginal ring for non‑hormonal birth control
Testing a vaginal ring that slowly releases an antibody to trap sperm and prevent pregnancy for people seeking non‑hormonal contraception.
-
A woman-controlled, nonhormonal on-demand contraceptive device
This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.
-
Vaginal ring releasing non-hormonal antibody contraception for month-long use
A monthly vaginal ring delivers a non-hormonal antibody-based contraceptive, offering a convenient, user-controlled option for women who want to avoid daily dosing or invasive procedures.
-
On-demand non-hormonal vaginal contraception with a fast-dissolving antibody tablet
A new on-demand vaginal tablet dissolves quickly to release a monoclonal antibody for non-hormonal contraception.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.